Since adipogenesis underlies obesity and consequent adipocytokine secretion, and several adipocytokines are cancer-promoting (e.g., leptin), KLF9 and KLF13 may significantly affect cancer pre-disposition indirectly through their targeted actions on fat depots. The gene discussed is LEP; the disease is cancer.